Top news

View all

Gavi Board appoints Senator Dr Sania Nishtar as Chief Executive Officer

Today, the Board of Gavi, the Vaccine Alliance approved the appointment of Dr Sania Nishtar as its next Chief Executive Officer.

COVID-19 vaccinations shift to regular immunisation as COVAX draws to a close

COVAX will close 31 December 2023 having delivered nearly 2 billion doses of vaccines to 146 economies, and averted an estimated 2.7 million deaths in AMC lower-income participating economies.

Gavi and Alliance partners renew support for immunisation in Mozambique

A high-level mission comprising Gavi, the Vaccine Alliance, the WHO, UNICEF, Bill & Melinda Gates Foundation and World Bank is scheduled to visit the Republic of Mozambique from 10 December, aiming to renew political commitment towards…

COVAX data brief

Regular snapshot of latest information on key COVAX data points, including shipments, donations, coverage, administration, absorption and delivery support.

View all

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

Huma Ashraf, an unbroken spirit

The frontline worker who lost her feet in a train accident, but never the resolve to eradicate polio from Pakistan.

Two vaccines, one target: How the RTS,S and R21 malaria vaccines work

After decades of development and testing, the malaria vaccines now being rolled out across Africa are the first to ever successfully target a parasite, rather than a virus or bacterium. But how do these revolutionary vaccines work? 

Outbreak-hit Zimbabweans embrace cholera vaccines with open arms

Fears of a repeat of 2008’s devastating epidemic recede as residents welcome roll-out of 2.3 million doses of oral cholera vaccine. 

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Our impact

Children >1 billion children vaccinated through routine programmes
First aid locator >17.3 million future deaths averted
Transitioned 19 countries fully self-financing
Billions >220.5 US$ billion in economic benefits for countries
Syringe 1.8 billion vaccinations through preventive vaccination campaigns

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter